M. Christman

MCC Statistical Consulting LLC, Gainesville, FL, USA

Health Outcomes Studied

• Increased Anti-Inflammatory Cytokine Levels
• Increased Fecal Bifidobacteria Levels
• Increased Interleukin-10 Levels
• Increased Lactic Acid Bacteria Levels

Papers (7)

• 2020
  Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study10.1080/19390211.2020.1749751
• 2017
  Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial.10.3945/ajcn.116.140012
• 2016
  Calcium phosphate supplementation increases faecal Lactobacillus spp. in a randomised trial of young adults.10.3920/BM2014.0168
• 2016
  Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial10.1017/S0007114516001665
• 2015
  Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study10.1080/07315724.2014.983249
• 2015
  Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study10.1017/S0007114514003997
• 2015
  Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults.10.3920/BM2014.0031